DASSAULT SYSTEMES
SUPPLEMENTAL NON-IFRS FINANCIAL INFORMATION
IFRS – NON-IFRS RECONCILIATION
(unaudited; in millions of Euros, except per share data and percentages)
Readers are cautioned that the supplemental non-IFRS information presented in this press release is subject to inherent limitations. It is not based on any comprehensive set of accounting rules or principles and should not be considered as a substitute for IFRS measurements. Also, the Group’s supplemental non-IFRS financial information may not be comparable to similarly titled non-IFRS measures used by other companies. Further specific limitations for individual non-IFRS measures, and the reasons for presenting non-IFRS financial information, are set forth in the Group’s Document d’Enregistrement Universel for the year ended December 31, 2019 filed with the AMF on March 19, 2020. To compensate for these limitations, the supplemental non-IFRS financial information should be read not in isolation, but only in conjunction with the Group’s consolidated financial statements prepared in accordance with IFRS.
|
In millions of Euros, except per share data and percentages |
Three months ended March 31, |
Change |
||||||
|
2020 |
Adjustment(1) |
2020 |
2019 |
Adjustment(1) |
2019 |
IFRS |
Non-IFRS(4) |
|
|
IFRS |
Non-IFRS |
IFRS |
Non-IFRS |
|||||
|
Total Revenue |
€ 1,134.7 |
€ 9.7 |
€ 1,144.4 |
€ 958.9 |
€ 5.1 |
€ 964.0 |
18% |
19% |
|
Total Revenue breakdown by activity |
||||||||
|
Software revenue |
1,014.2 |
8.8 |
1,023.0 |
855.3 |
4.2 |
859.5 |
19% |
19% |
|
Licenses and other software revenue |
172.3 |
172.3 |
213.2 |
213.2 |
(19)% |
(19)% |
||
|
Subscription and Support revenue |
841.9 |
8.8 |
850.7 |
642.0 |
4.2 |
646.2 |
31% |
32% |
|
Recurring portion of Software revenue |
83% |
|
83% |
75% |
|
75% |
|
|
|
Services revenue |
120.5 |
0.9 |
121.4 |
103.6 |
0.9 |
104.5 |
16% |
16% |
|
Total Software Revenue breakdown by product line |
||||||||
|
Industrial Innovation |
604.3 |
0.7 |
605.1 |
605.1 |
605.1 |
(0)% |
(0)% |
|
|
Of which CATIA |
270.3 |
0.7 |
271.1 |
270.1 |
270.1 |
0% |
0% |
|
|
Of which ENOVIA (2) |
80.6 |
80.6 |
89.0 |
89.0 |
(9)% |
(9)% |
||
|
Life Sciences (3) |
187.2 |
7.8 |
195.0 |
39.0 |
0.2 |
39.3 |
380% |
396% |
|
Mainstream Innovation |
222.7 |
0.3 |
223.0 |
211.1 |
4.0 |
215.1 |
5% |
4% |
|
Of which SOLIDWORKS |
201.5 |
201.5 |
191.4 |
191.4 |
5% |
5% |
||
|
Total Revenue breakdown by geography |
||||||||
|
Americas |
444.6 |
9.2 |
453.8 |
307.0 |
4.0 |
311.1 |
45% |
46% |
|
Europe |
421.2 |
0.2 |
421.5 |
408.4 |
1.1 |
409.5 |
3% |
3% |
|
Asia |
268.8 |
0.3 |
269.1 |
243.5 |
243.5 |
10% |
11% |
|
|
Total Operating Expenses |
€ (983.7) |
€ 173.4 |
€ (810.3) |
€ (743.1) |
€ 95.5 |
€ (647.6) |
32% |
25% |
|
Share-based compensation expense and related social charges |
(44.4) |
44.4 |
- |
(46.3) |
46.3 |
- |
||
|
Amortization of acquired intangible assets and of tangible assets revaluation |
(109.4) |
109.4 |
- |
(50.1) |
50.1 |
- |
||
|
Lease incentives of acquired companies |
(0.7) |
0.7 |
- |
- |
- |
- |
||
|
Other operating income and expense, net |
(18.9) |
18.9 |
- |
0.9 |
(0.9) |
- |
||
|
Operating Income |
€ 151.0 |
€ 183.1 |
€ 334.1 |
€ 215.8 |
€ 100.6 |
€ 316.4 |
(30)% |
6% |
|
Operating Margin |
13.3% |
29.2% |
22.5% |
|
32.8% |
|
|
|
|
Financial revenue & other, net |
(6.5) |
0.3 |
(6.3) |
5.2 |
(0.9) |
4.2 |
(227)% |
(249)% |
|
Income tax expense |
(35.3) |
(44.5) |
(79.8) |
(62.9) |
(32.3) |
(95.2) |
(44)% |
(16)% |
|
Non-controlling interest |
3.2 |
(1.3) |
1.9 |
2.8 |
(1.8) |
1.0 |
16% |
91% |
|
Net Income attributable to shareholders |
€ 112.4 |
€ 137.6 |
€ 250.0 |
€ 160.8 |
€ 65.7 |
€ 226.5 |
(30)% |
10% |
|
Diluted Net Income Per Share (5) |
€ 0.43 |
€ 0.52 |
€ 0.95 |
€ 0.62 |
€ 0.25 |
€ 0.87 |
(31)% |
9% |
